MedPath

Study to compare ropivacaine and bupivacaine for lower abdomen and lower limb surgeries under spinal anaesthesia.

Phase 4
Conditions
Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangreneHealth Condition 2: N813- Complete uterovaginal prolapseHealth Condition 3: N430- Encysted hydroceleHealth Condition 4: S820- Fracture of patellaHealth Condition 5: S821- Fracture of upper end of tibiaHealth Condition 6: K409- Unilateral inguinal hernia, without obstruction or gangrene
Registration Number
CTRI/2023/09/057269
Lead Sponsor
Dr Kavya Kanjikkal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing lower abdomen surgeries giving consent to participate in study. Age between 18 to 65 years. Body weight between 45 to 70 kg. ASA grade I and II

Exclusion Criteria

Patients refusal

ASA grade III and IV

Patients with severe respiratory, cardiovascular, renal diseases, obesity

Infection

Coagulopathy

Spinal deformity

Allergic to local anaesthetic drugs

History of seizure and neurological deficit

Age below 18 years and above 65 years

weight below 45kg and above 70 kg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected more hemodynamic stability in 0.75% Ropivacaine compared to bupivacaine during spinal anaesthesia intraoperatively & post operativelyTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Expected better cardiac stability in 0.75% Ropivacaine than BupivacaineTimepoint: 24 hours;expected early sensory & motor block in 0.75 % Ropivacaine than BupivacaineTimepoint: 24 hours;Expected faster recovery early mobilization & micturition in Ropivacaine compared to bupivacaineTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath